Interferon beta-1a during a first demyelinating event (multiple letters) [2]

New England Journal of Medicine

Volumn 344, Issue 3, 2001, Pages 229-230

  Poser, Charles M ^a   Esmonde, Thomas F G ^b   Jacobs, Lawrence D ^c   Beck, Roy W ^d   Kinkel, R Phillip ^e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

^c BUFFALO GENERAL HOSPITAL   (United States)

^d JAEB CENTER FOR HEALTH RESEARCH   (United States)

^e Mellen Center for Multiple Sclerosis Treatment and Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; CORTICOSTEROID; BETA INTERFERON;

CHRONIC FATIGUE SYNDROME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMYELINATING DISEASE; DRUG EFFICACY; ENCEPHALOMYELITIS; HUMAN; LETTER; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE DISEASE; PRIORITY JOURNAL; TREATMENT OUTCOME; DISEASE COURSE; METHODOLOGY; MYELITIS; OPTIC NEURITIS; DIAGNOSTIC ERROR;

DISEASE PROGRESSION; HUMANS; INTERFERON-BETA; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; MYELITIS, TRANSVERSE; OPTIC NEURITIS; RESEARCH DESIGN; DIAGNOSTIC ERRORS;

EID: 0035905910     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200101183440313     Document Type: Letter

References (0)